CASP1 and autoimmune hepatitis: The key role of IL-18 in AIH was further supported by the mitigation of hepatic inflammation through the implementation of caspase-1 inhibitors, IL-18 monoclonal antibodies, and soluble IL-18 inhibitors (Figure 17) (Ikeda et al., 2014).